Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes In Stockholders' Equity (Unaudited)

v3.21.1
Condensed Consolidated Statements of Changes In Stockholders' Equity (Unaudited) - USD ($)
Series H Preferred Stock [Member]
Series H-3 Preferred Stock [Member]
Series H-6 Preferred Stock [Member]
Series Seed Preferred Stock [Member]
Common Stock [Member]
Additional Paid-In Capital [Member]
Accumulated (Deficit) [Member]
Total
Balance at Dec. 31, 2019       $ 9,025,245 $ 395 $ 5,001,947 $ (13,958,644) $ 68,943
Balance, shares at Dec. 31, 2019       7,360,985 3,948,078      
Stock based compensation       156,459 156,459
Net Loss       (1,795,153) (1,795,153)
Balance at Mar. 31, 2020       $ 9,025,245 $ 395 5,158,406 (15,753,797) (1,569,751)
Balance, shares at Mar. 31, 2020       7,360,985 3,948,078      
Balance at Dec. 31, 2019       $ 9,025,245 $ 395 5,001,947 (13,958,644) 68,943
Balance, shares at Dec. 31, 2019       7,360,985 3,948,078      
Balance at Dec. 31, 2020   $ 2,709 64,509,724 (25,154,817) 39,357,616
Balance, shares at Dec. 31, 2020 8 1,234 50   27,088,584      
Stock based compensation   1,699,423 1,699,423
Sale of common stock, net of fees   $ 804 58,269,025 58,269,829
Sale of common stock, net of fees, shares         8,035,835      
Exercise of warrants   $ 1 99,999 100,000
Exercise of warrants, shares         13,642      
Exercise of stock options   $ 7 183,418 $ 183,425
Exercise of stock options, shares         74,987     74,987
Net Loss   (5,633,833) $ (5,633,833)
Balance at Mar. 31, 2021   $ 3,521 $ 124,761,589 $ (30,788,650) $ 93,976,460
Balance, shares at Mar. 31, 2021 8 1,234 50   35,213,048